- •
Acute respiratory distress syndrome (ARDS) occurs in more than 10% of intensive care unit admissions and nearly 25% of ventilated patients.
- •
Low-volume, low-pressure lung protective ventilation remains the mainstay of ARDS management.
- •
In severe ARDS, early use of neuromuscular blockade and prone positioning improve survival.
- •
High-frequency oscillatory ventilation has no clear mortality benefit and may harm some patients.
- •
Extracorporeal membrane oxygenation consultation should be obtained early to
Optimal Strategies for Severe Acute Respiratory Distress Syndrome
Section snippets
Key points
Epidemiology of severe acute respiratory distress syndrome
The review of acute lung injury (ALI) and ARDS epidemiology by Blank and Napolitano9 summarized the most current trends in respiratory survival development and outcomes in modern ICU care. These investigators made the following observations:
- •
This is a heterogeneous condition that occurs in heterogeneous ICU populations
- •
The incidence of ALI/ARDS is declining because of a decrease in hospital-acquired respiratory failure
- •
The mortality associated with ARDS remains high at 20% to 25% in randomized
Standard Ventilator Management
The goal of the management of severe ARDS is to safely support gas exchange without further injuring the patient’s lungs.16 The optimal initial approach seems to be a low-volume, low-pressure ventilation strategy with volume control ventilation, which showed a survival benefit in the ARDSNet ARMA (Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome) trial.17 This lung protective strategy limits the
Advances in nonventilator management
Nonventilatory adjunctive therapies also play an important role in the management of patients with moderate to severe ARDS. In recent years, important studies have shown a potential survival benefit with the use of these therapies, whereas others have not been proved beneficial or have even been found to be associated with harm. The roles of neuromuscular blockade, prone positioning, and inhaled pulmonary vasodilators in patients with severe ARDS are discussed later in this article.
Extracorporeal membrane oxygenation
Venovenous ECMO (VV ECMO) has assumed an important role in the management of patients with severe ARDS (Fig. 4). In the past decade, the number of adults with severe ARDS managed with ECMO and the number of self-identifying adult ECMO centers has increased greatly.49, 50 The landmark Conventional Ventilation or ECMO for Severe Adult Respiratory Failure (CESAR) trial and the influenza A (H1N1) pandemic served to raise awareness of the technologic advances in this field and of the excellent
Summary
Several insights into the clinical entity of ARDS have been gleaned over the past several years even as the care of these patients has continued to advance in many ways. Nonetheless, much work is still required to promote early diagnosis of ARDS and the application of evidence-based ventilator management principles in these patients. High-frequency ventilation has not shown a clear benefit in patients with severe ARDS, but other modes of ventilator support, such as APRV, may have a continued
References (71)
- et al.
ALI and ARDS: challenges and advances
Crit Care Clin
(2011) - et al.
Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with acute respiratory distress syndrome
Chest
(2016) - et al.
Epidemiology of ARDS and ALI
Crit Care Clin
(2011) - et al.
Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients
Chest
(1992) - et al.
Airway pressure release ventilation in acute respiratory distress syndrome
Crit Care Clin
(2011) - et al.
Prone-positioning therapy in ARDS
Crit Care Clin
(2011) - et al.
High-flow oxygen therapy and other inhaled therapies in intensive care units
Lancet
(2016) - et al.
Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS
Chest
(2000) - et al.
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
Lancet
(2009) - et al.
Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome
Crit Care Clin
(2011)
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
Lancet
Acute respiratory distress syndrome: the Berlin definition
JAMA
Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries
JAMA
Therapeutic strategies for severe acute lung injury
Crit Care Med
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
Intensive Care Med
Severe respiratory failure: advanced treatment options
Crit Care Med
Lung recruitability is better estimated according to the Berlin definition of acute respiratory distress syndrome at standard 5 cm H2O rather than higher positive end-expiratory pressure: a retrospective cohort study
Crit Care Med
A pig hemorrhagic shock model: oxygen debt and metabolic acidemia as indicators of severity
Shock
The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome
Ann Intern Med
Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway
Am J Respir Crit Care Med
Acute lung injury: a clinical and molecular review
Arch Pathol Lab Med
Ventilator-induced lung injury
N Engl J Med
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
N Engl J Med
Lung protective ventilation strategy for the acute respiratory distress syndrome
Cochrane Database Syst Rev
Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome
N Engl J Med
Mechanical ventilation guided by esophageal pressure in acute lung injury
N Engl J Med
Mechanical ventilation of adults in acute respiratory distress syndrome
UpToDate
Do the NIH ARDS clinical trials network PEEP/FIO2 tables provide the best evidence-based guide to balancing PEEP and FIO2 settings in adults?
Respir Care
Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis
JAMA
Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial
JAMA
Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial
JAMA
Driving pressure and survival in the acute respiratory distress syndrome
N Engl J Med
Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS)
Cochrane Database Syst Rev
Recruitment maneuvers for acute lung injury: a systematic review
Am J Respir Crit Care Med
Cited by (21)
Prone positioning in patients with acute respiratory distress syndrome, translating research and implementing practice change from bench to bedside in the era of coronavirus disease 2019
2021, Australian Critical CareCitation Excerpt :The first task the PWC undertook was a critical review of the relevant literature related to proning and assessing the level of evidence for the PPP. The PWC reviewed the literature, meta-analysis, and guidelines published on ARDS management over the last ten years.6,15,16,22,24–30 Based on the findings from the review of the literature, as well as current international guidelines and procedures, the PWC planned and wrote the work unit guidelines.
Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS
2020, American Journal of Emergency MedicineCitation Excerpt :In COVID-19 related respiratory failure, care is focused on maintaining oxygenation while preventing VILI with lung protective ventilation (LPV). The mainstays of LPV are low VT, sufficient PEEP to maintain lung recruitment, and low airway pressures [17,30-34]. Though ARDS is a heterogeneous syndrome, the following is recommended for all ARDS patients: (1) VT of 4 to 8 mL/kg predicted body weight (PBW) and (2) targeting a PPlat <30 cm H2O (Tables 3 and 4) [15,34,35].
Intraoperative initiation of a modified ARDSNet protocol increases survival of septic patients with severe acute respiratory distress syndrome
2018, Heart and LungCitation Excerpt :Selection of PEEP was based on gas exchange and hemodynamics and was adjusted by one of the ARDSNet PEEP/FiO2 tables.11–14 Although this protocolized approach has been associated with inadequate venous return and barotrauma, a trend towards improved mortality using the high-PEEP table has been reported.15,16 However, other studies demonstrated no benefit or an association with further lung injury.7,17–19
Salvage therapies for refractory hypoxemia in ARDS
2018, Respiratory MedicineCitation Excerpt :The Berlin definition categorizes severe ARDS based on the degree of hypoxemia, as a Pa02/FiO2 ratio less than 100, with a mortality rate of 45% [1]. According to the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory failure (LUNGSAFE study), the estimated incidence of ARDS is around 34 cases per 100, 000 patients per year in the United States [2,3]. 23.4% of the patients in this group had severe ARDS defined based on the Berlin criteria [2].
Extracorporeal membrane oxygenation in acute respiratory and cardiac failure: An increasingly accessible therapy
2017, Revista Portuguesa de CardiologiaAlveolar Emptying in Mechanical Ventilation
2017, Archivos de Bronconeumologia
The opinions expressed in this document are solely those of the authors and do not represent an endorsement by or the views of the United States Air Force, the Department of Defense, or the United States government.
Disclosure: Dr D. Brodie is currently on the medical advisory boards of ALung Technologies and Kadence. All compensation for these activities is paid to Columbia University. Drs J.W. Cannon and J.T. Gutsche report nothing to disclose.